U.K. Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency to determine whether the vaccine ``meets rigorous safety standards.''

The news comes days after the shots were described as 'highly effective' with no mention of why some participants didn't receive as much vaccine as expected.